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Protein I: Structure, Function, and Genetics
RALPH C. JUDD
Division of Biological S(ietes, University of AMontana, Missouila, Montana 59812
The study of the major outer membrane (OM) protein,
protein I (PI), of Neisseria gonorrhoeae has proven to be as
fascinating, and as frustrating, as every other aspect of this
remarkable bacterium. However, intensive studies over the
last few years have provided significant insight into the
structure, function, and genetics of this abundant, surface-
exposed porin protein. There are two forms of PI, which
share up to 80% homology. The diversity of the exposed
portion of the molecules among strains presents an ever-
changing immunogenic and antigenic dilemma to the rein-
fected host. Yet, it is the variability of the PI surface
epitopes that has provided a precise method of serotyping N.
gonorrhoeae, making it possible to monitor the prevalence
and spread of strains within the host population and corre-
late functional differences between strains with PI structural
types.
Recent successes in cloning and sequencing of both P1
structural subclasses have already contributed to our under-
standing of the mechanisms) whereby N. gonorrhoeae
generates PI structural diversity. Continued investigation is
needed to clarify the relationship between PI type and
disseminated disease, resistance to serum killing, auxotypic
requirements, interaction with host cells, and resistance to
antibiotics. Observations regarding the ability of PI to inter-
act with eucaryotic membranes suggest a role for PI in the
pathogenesis of N. gonorrhoeae, whereas immune respon-
siveness of patients to PI points to the possibility of a PI
vaccine. Clearly, at the molecular level, PI represents all the
mystery and intrigue that N. gonorrhoeae presents at the
organism level. Certainly, much remains to be learned
before we have a complete picture of the structure, function,
and genetics of PI.
STRUCTURE
PI (73) is known to exist in two structurally related forms,
designated subclass PIA and subclass PIB (61), which have
different orientations in the OM (2, 4). A given strain or N.
gonorrhoeae expresses a single, invariant PI of one of the
other subclass, which accounts for up to 60% of the protein
in the OM (36), whether grown aerobically or anaerobically
(16). There is significant structural variation within the
subclasses, resulting in proteins of different apparent molec-
ular mass (52, 72), different isoelectric points (with some as
low as 5.5, but most close to 8.0) (3), and unique immuno-
logical reactivities (6, 45, 61-63, 75). PIAs tend to be smaller
than PIBs, ranging in apparent molecular mass from about 34
to 36.5 kilodaltons (kDa), whereas PIBs range from about 36
to 38 kDa (38, 52, 72, 73) (Fig. 1). Regardless of subclass, PIs
appear to associate as trimeric porins which form hydro-
philic channels through the OM (3, 19, 51, 78). Proteins of
both subclasses show immunological variation (6, 45, 61-63,
75), which tends to be localized in surface-exposed portions
of the molecules (13, 40, 42, 44, 46, 75). PIs also interact with
other OM components, such as protein III (PIII) (55, 74) and
lipooligosaccharide (LOS) (31), to form complex OM struc-
tures.
The amino acid sequences of a representative PIA (strain
S41
FA19) (14) and two PIBs (strains RIO [23] and MS11 [13]) are
known. PIA and PIB have identical 19-amino-acid leader
sequences which are cleaved to produce the functional
protein (13, 14, 23). There is 65 to 80% homology between
PIA and amino acid sequences of the two PIBs, confirming
similarities previously observed by peptide mapping (2, 39,
40, 61, 72). Peptide mapping studies of PIAs and PIBs and
sequence data for two PIBs (13) indicate that there is a
higher degree of homology within the subclasses (2, 44, 61,
72). The predicted molecular masses from the deoxyribonu-
cleic acid (DNA) sequences are about 34 kDa for the PIA
and 35.5 to 36 kDa for the PIBs. These masses are remark-
ably close to the apparent molecular masses derived by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
and are consistent with the masses of Escherichia (0li porin
proteins (14, 20, 23). Additionally, the PI sequences reveal
an absence of long hydrophobic stretches and a lack of
cysteine, and they have about 23% sequence homology with
E. coli trimeric porins (23). Hydropathy patterns of the
predicted PI sequences are also consistent with patterns of
E. coli OmpC and OmpF porins (14), providing evidence that
PI molecules act as porin proteins, forming hydrophilic
channels across the OM (3, 19, 51, 78).
Sequence differences between the PIA and PIB subclasses
result in different orientations of the PIs in the OM (Fig. 2).
PIAs are oriented in the OM in such a manner that they have
a relatively small portion (15 to 20 amino acids) of the protein
exposed on the bacterial surface (2, 4, 42, 44, 68). PIBs
traverse the membrane at least twice, having, perhaps, both
termini embedded in the OM (2, 4, 68). Thus, PIAs are
resistant to in situ proteolysis by trypsin and c-chymotrypsin
(2, 4, 44, 68), with only a short portion of the molecule being
susceptible to cleavage by proteinase K. Cleavage of purified
PIAs from two strains of N. gonorrhoeae with leucine
aminopeptidase, followed by immunoblot analysis, indicated
that the N-terminus is the exposed portion of PIAs (42). A
very recent study (13), in which shuttle mutagenesis was
used to introduce a selectable marker near the PI gene, used
transformation to locate surface epitopes of PIA and PIB in
PIA-PIB hybrids. This study confirmed the N-terminal ex-
posure of PIA, but suggested that there may be C-terminal
exposure as well.
PIBs are very susceptible to in situ cleavage by exogenous
proteases such as trypsin, ox-chymotrypsin, and proteinase K
and by neutrophil proteases such as elastase and cathepsin G
(W. M. Shafer, personal communication), which cleave a
central portion of the molecule, leaving two membrane-
bound fragments (2, 4, 44). Cleavage of purified PIBs with
CNBr (76) and endopeptidases (21), followed by immunoblot
analysis, demonstrated that the central portion of PIB is the
surface-exposed portion of the molecule. Analysis of PIA-
PIB hybrids suggested that a portion of the N terminus may
also be exposed in PIBs (13). The portions of the PIs that are
exposed on the surface tend to be variable (13, 40, 42, 44, 46,
75) and possess epitopes which allow for immunological
classification of strains based on the structural variation
within the PIA and PIB subclasses (6, 46, 61-63, 75).
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FIG. 1. Separation of whole-cell lysates of N. gonorrhoeae JS1,
5776, 8658, JS2, CS7, FA19, FA638, JS3, 7929, and JS4 by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis in a 12.5% gel.
The top panel is the central portion of a Coomassie brilliant blue
(CBB)-stained gel which shows the range of apparent molecular
masses of PI. The apparent molecular masses, expressed in kilodal-
tons (K), of the PI of each strain, as determined by comparison with
the Bio-Rad low-molecular-weight markers (mw) are as follows:
JS1, 37.7 kDa; 5776, 36.9 kDa; 8658, 37.3 kDa; JS2, 36.3 kDa; CS7,
35.7 kDa; FA19, 35.7 kDa; FA638, 35.7 kDa; JS3 35.7 kDa; 7929,
35.2 kDa; and JS4, 34.6 kDa. The middle panel is an immunoblot
using the PIB-specific 3C8 MAb (75), and the bottom panel is an
immunoblot using the PIA-specific 4G5 MAb (75). Both blots were
probed with anti-mouse IgG-horseradish peroxidase. The PI sub-
class of each strain, as determined by 1251I-labeled peptide mapping
(42), is given as a subscript to each strain designation. Note that
although the PIBs tend to be larger than the PlAs, there is consid-
erable overlap in their apparent molecular masses. Also note that
not all PIs bind these widely reactive anti-PI MAbs (e.g., strains JS3
and JS4), necessitating further analyses to determine the PI subclass
of these nonreactive strains.
Initial efforts to serotype N. gonorrhoeae involved the use
of antisera raised against OM vesicles (36). PI was a domi-
nant antigen in these vesicles (36, 52), indicating that it might
be useful in serotype analyses. Sandstrom and Danielsson
(63), using absorbed polyclonal antisera in coagglutination
assays, were able to separate N. gonorrhoeae into three
serogroups designated WI, WII, and WIII. A second method
of serogrouping, involving the use of anti-PI antibodies in an
enzyme-linked immunosorbent assay, was developed by
Buchanan and Hildebrandt (6). This system divided gono-
cocci into nine serotypes. Further studies showed that both
serogrouping systems correlated with the PI subclass: the
WI strains and serogroup 1 to 3 have a PIA, and the WII and
WIlI strains and serogroups 4 to 9 have a PIB (61, 63). A
series of PI-specific monoclonal antibodies (MAbs) have
since been produced (Fig. 1) which react with different
epitopes on or near the surface-exposed portion of the PI
molecules (46, 75). On the basis of the reactivity patterns to
these "banks" of PIA- or PIB-specific MAbs in coagglutina-
tion assays, systems of serotyping have been developed that
classify strains into serovariants, or serovars. Thus, strains
of N. gonorrhoeae can be described by their PI subclass and
the reactivity of the PI with the serovar MAbs (e.g., PIA-1
indicates that this strain has a PIA that reacts with all six of
the serovar MAbs) (46, 65, 75). The large number of serovar
patterns demonstrates the wide structural variation in or
around the surface-exposed regions of the PIs (45, 46, 75).
Exposure analyses have confirmed the structural variability
of the surface-exposed regions of the PIs (21, 40, 42, 44, 76).
Primary structural differences are not the only factors
affecting PI structure in the OM. PI molecules interact to
form trimeric porin structures (3, 51). PIII also interacts with
PI in the OM in a ratio of three PIII molecules to one PI
molecule, forming a complex that can be chemically cross-
linked (55). Swanson et al. (74) confirmed an in situ associ-
ation of PI and PTTT by demonstrating that anti-PIII MAb
coprecipitated PI. PIII may therefore participate in the
formation, stabilization, and/or operation of the trimeric PI
pore. A noncovalent association between LOS and PI has
also been demonstrated (31). Although the nature of this
association is not known, variation of LOS structure does
correlate with differences in PI exposure in strains of N.
gonorrhoeae having structurally identical PIAs or PIBs
(R. C. Judd and W. M. Shafer, Mol. Microbiol., in press).
Recent studies have demonstrated that PI is associated with
peptidoglycan (PG) (S. A. Hill, Ph.D. thesis, University of
Montana, Missoula, 1987), perhaps serving to anchor the
GM to PG at critical sites. Neither protein ITs, pili, nor H.8
antigen appear to interact directly with PI in the OM (32, 60).
A recent study by Robinson et al. (60) demonstrated that the
availability of PI to bind PI-specific MAb and polyclonal
antibody in intact cells varied extensively, even within the
same culture. This raises the possibility that structurally
identical PIs do not have the same orientation in all cells;
that PI is not expressed in all cells; or that some other, as yet
undescribed, interaction between PI and another OM com-
ponent(s) is occurring differently in different cells (60).
FUNCTION
The known function of PI is to form hydrophilic pores
across the OM (porin) (3, 19, 51). The porin function of PI is
clearly necessary for the survival of the bacterium, allowing
nutrients to penetrate into the cell and waste materials to
exit. Other possible cellular functions of PI have been
suggested, such as translocation into recipient membranes
(3, 49) and association with PG (Hill, Ph.D. thesis). PI
subclass has been associated with such traits as serum
resistance (12, 29, 38, 57), resistance to antibiotics (1, 8, 33,
35, 59), auxotype (5, 24, 47, 54, 64), and expression of type
1 or type 2 immunoglobulin Al (IgAl) protease (54). The role
of PI in pathogenesis remains elusive, but the PI subclass has
been associated with certain clinical states such as dissemi-
nated gonococcal infection and localized mucosal disease (5,
9, 50, 54, 56, 64).
The porin activity of PIs has been investigated by analyz-
ing their ability to conduct electric currents when- placed in
lipid bilayers (3, 49, 51, 78). PIs inserted into artificial
membrane bilayers conducted current in bursts, indicating
S42 JUDD
PROTEIN I S43
PIB
Out side
OM
Inside
C 2 '.. 12
.. :..
I
PIA
oC/\PK
_I.h3PK,
Cleavage
PK2 PK1
FIG. 2. Model of PIB and PIA in OMs of N. gonorrhoeae based on in situ cleavage by a-chymotrypsin (aC) or proteinase K (PK). The
PIs were cleaved to yield the fragments shown in this model. C1. C., PK,', which is further cleaved to produce the PK, fragment. and PK,
are produced when PIB-bearing strains are treated with x-chymotrypsin proteinase K. The PK, fragment is generated when PIA-bearing
strains are treated with proteinase K. PlAs are resistant to in situ cleavage by a-chymotrypsin and trypsin. On the basis of these cleavage
patterns, PIB has a central portion of the molecule exposed on the surface, with both termini embedded in the membrane, whereas PlAs have
a short portion of the N terminus (42) exposed on the bacterial surface. Reproduced from Infection and Immunity (2) with permission of the
publisher.
the pores existed in two states, open or closed (3, 49).
Moreover, gonococcal PIs showed incremental voltage gat-
ing of current across a lipid bilayer in a manner characteristic
of trimeric porins (20, 51). Thus, PIs appear to be porins with
three PI molecules combining to form hydrophilic channels,
through the OM (Fig. 3). The diameter of the pore has been
estimated to be 2.5 nm (19), with an anion-selective channel
ranging in Cl-/K' selectivity from 6:1 (for PIBs) to 3:1 (for
PIAs) (3, 78).
Further studies with lipid bilayers have indicated that
gonococcal PIs spontaneously insert into these membranes
in an inverted manner (3, 49). The rate of insertion of N.
gonorrhoeae PIs was lower for PIBs (5 to 10 pores per h)
than for PIAs (100 pores per h) when 106 organisms were
placed in the test system. In comparison, Neisseria sicca did
not transfer porin function to the bilayer, even when 109
organisms were used, whereas 106 organisms of Neisseria
meningitidis transferred up to 1,500 pores per h (3, 49).
Interestingly, gonococcal strains isolated from patients with
disseminated disease had greater pore-forming activity than
did strains isolated from mucosal sites (3), perhaps reflecting
the observation that 80 to 90% of disseminated gonococcal
infection isolates express the PIA subclass. It has been
demonstrated that PI can be inserted into erythrocytes (3)
and that transfer is facilitated when the recipient membrane
is more fluid than the bacterial OM (3). The effect of this
transfer on pathogenesis is unclear. It has been shown that
neutrophils pretreated with purified PI had a decreased
ability to exocytose granules and, in response to stimulation
with N-formyl-Met-Leu-Phe, failed to increase their surface
area and did not aggregate as well as control cells (25). PI has
also been shown to bind calmodulin (3), a eucaryotic-
cell-regulatory molecule. The effect of these activities on
pathogenesis remains unclear, but is seems reasonable that
PI mediates important events in host cells that contribute to
bacterial survival and pathogenesis.
N. gonorrhoeae lacks a protein analogous to Braun's
lipoprotein found in E. coli (26). Recently, PI has been
shown to be one of several PG-associated proteins (30).
suggesting that PI may help bind the OM to PG. This is
supported by the observation that PI binds lectins that are
specific for sugars found in gonococcal PG (Hill, Ph.D.
thesis). Moreover, antibody raised against highly purified
PIB (R.C. Judd, Abstr. Third Biannual UA/UC Conf. Patho-
genic Bacteria, abstr. no. 5, p. 1) cross-reacted extensively
with several other PG-associated proteins, while antibody
made to a purified 60-kDa PG-associated protein reacts with
PI, indicating that PI shares epitopes, probably of PG origin,
with these molecules.
Protein I has been associated with several traits that are
important to disease. The availability of serotyping reagents
(46, 75) has made it possible to correlate PI subclass with
many characteristics of the organism as well as the nature of
the infection caused by a particular isolate. PIA has been
associated with resistance to killing by normal human serum
(29, 38, 57). As with most things gonococcal, the association
is not absolute. A recent study comparing susceptibility to
killing by normal human serum in transformant strains which
have identical PIAs or PIBs in differing LOS and H.8 antigen
backgrounds demonstrated that PI subclass does not ac-
count for serum resistance (R. K. Pettit, J. C. Szuba, and
R. C. Judd, unpublished data), confirming that other bacte-
rial components must play a role in resistance (11, 12.
69-71).
There does appear to be a relationship between PT sub-
class and antibiotic resistance. Several studies indicate that
resistance to rifampin (8), thiamphenicol (8), ampicillin (59),
and penicillin (59, 67) correlates strongly with the PIB
subclass. Correlations between PI subclass and antibiotic
resistance are somewhat dependent on geographical location
(33, 35, 59), and both PIA- and PIB-bearing strains are
capable of plasmid- and chromosome-mediated resistance to
antibiotics. There is a consistent correlation between the
arginine- hypoxanthine- uracil- (AHU-) auxotype and PIA
(5, 24, 47, 54, 64). Other auxotypes do not correlate as
strongly with a particular PI subclass. Therefore, serotyping
schemes have been developed which combine the PI serovar
and auxotype to classify gonococcal isolates (24, 45).
Another association regarding PI subclass is the produc-
tion of type 1 IgAl protease, which is produced predomi-
nantly by AHU-, PIA-bearing strains, and type 2 IgAl
protease, which is produced by many other auxotypes and
serovars (54). The AHU- auxotype and PIA subclass do
correlate with the ability to cause disseminated infection (5,
9, 47, 50, 54, 56. 64); the majority (>85%) of blood isolates
possess the PIA subclass of PI, and about 60%o are AHU-
(47, 56). Mucosal isolates tend (>60%) to possess the PIB
subclass of PI. It is important to note that both PIA- and
VOL. 2, 1989
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FIG. 3. Three-dimensional reconstruction of the small hexagonal
form of a trimeric porin formed by E. coli matrix protein (OmpF) in
reconstituted phospholipid membranes as viewed externally (a) and
internally (b). Conductance measurements demonstrated a series of
voltage-dependent openings and closings indicative of a trimeric
pore as depicted in panel a. The three pores, which open and close
independently, merge to form a single channel on the periplasmic
side to the membrane (panel b). Conductance experiments on PI of
N. gonorrhoeae inserted into lipid membranes demonstrated similar
voltage-dependent gating data (51), indicating that PI forms trimeric
pores analogous to those formed by the E. coli matrix protein as
seen here. Reprinted from Nature (London) (20) with permission of
the publisher.
PIB-bearing strains have been isolated from blood, joints,
and mucosal sites (50, 56).
The host immune response to PI depends on previous
immune status (28, 66) and site (48, 56) and duration (22, 28,
79) of infection. Several studies have demonstrated that
normal human serum contains anti-PI antibody. In one
study, normal human serum was shown to specifically inhibit
anti-PI monoclonal antibody binding. This inhibiting anti-
body in normal human serum was opsonic (66). In a pre- and
posturethral infection study, immunoblot analysis showed
that 12 of 13 men possessed preformed anti-gonococcal
antibody, some directed against PI, perhaps being cross-
reactive antibody from previous exposure to N. meningitidis
or other gram-negative organisms (28). Following infection,
nine men showed a temporal increase in antibody levels
against gonococcal antigens, including PI (28). A study
comparing antibodies in serum and vaginal fluid from women
with disseminated gonococcal infection, peritoneal inflam-
matory disease, and uncomplicated mucosal infections indi-
cated that both IgG and IgA in vaginal fluid reacted more
strongly with PI of the infecting strain of N. gonorrhoeae
than did serum antibody (48). Radioimmunoprecipitation
studies of serum from sexual partners suffering from local-
ized mucosal infections demonstrated that both men and
women produced anti-PI antibody in their sera in response to
infection (79).
The role of anti-PI antibody in infection is unknown.
However, the possibility that anti-PI antibody is important in
limiting infection is supported by the observation that anti-
PIII antibody blocked the bactericidal activity of anti-PI
antibody in convalescent-phase serum (58), reflecting the
close association of PI and PIII in the OM. When anti-PIII
antibodies were removed from the serum, bactericidal activ-
ity was restored (58), indicating that anti-PI antibody in
patient serum can kill N. gonorrhoeae.
Many anti-PIA and anti-PIB MAbs are able to activate the
classical complement cascade, resulting in cell killing (27,
38, 77). The juxtaposition of the exposed PIA epitopes and
other OM components seems to be critical in determining
whether a particular MAb will be bactericidal, since MAbs
that activate equivalent amounts of complement and that
bind equivalently to cells showed marked differences in their
ability to kill N. gonorrhoeae (38). A similar situation
appears to occur with anti-PIB MAbs (77). The difference in
killing is related to the manner in which the activated
complement is deposited on the bacterial surface (37, 38).
Anti-PIA and anti-PIB MAbs have also been shown to be
opsonic and are able to inhibit the invasion of N. gonor-
rhoeae into epithelial cells (27).
The ability of anti-PI antibody to kill N. gonorrhoeae,
combined with the relative abundance of PIs, their universal
expression, the apparent structural similarity between PIs
within each subclass, their antigenic stability within a strain,
and the presence of anti-PI antibody in the mucus and
serum, even following uncomplicated mucosal infection, has
encouraged the use of PI as a potential vaccine. Purified PIB
has been used, unsuccessfully, in vaccine trials (Sexually
Transmitted Diseases 1986 National Institute of Allergy and
Infectious Diseases Study Group Summary and Recommen-
dations; K. K. Holmes, General Chairman; November
1987). In another study, recipients did show specific re-
sponses when injected with a PI preparation (F. Arminjon,
M. Cadoz, S. A. Morse, J. P. Rock, and S. K. Sarafian,
Abstr. Annu. Meet. Am. Soc. Microbiol. 1987, E92, p. 118).
Attempts to improve the immunogenicity of PI have been
made, especially by using liposomes as delivery vehicles
(34). Such studies indicate that both PI-detergent complexes
and PI-liposomes induce anti-PI antibodies but that PI-
liposomes elicit the larger primary response (34).
The immunodominant portion of the PI molecule appears
to be the most exposed region (13, 40, 42, 46, 75). Since this
region is also the variable part of the PI molecule, several
groups are attempting to identify conserved epitopes which
are available to bind anti-PI antibody. One approach is to use
MAbs to locate such regions (77). Another approach is to use
cloned PI genes to synthesize peptides of PI (13, 14, 23),
whereas others are using peptides generated by cleaving
purified PIs and recovering surface-exposed fragments for
immunogenicity and antigenicity studies (41, 43, 76).
GENETICS
The majority of information about the genetics of PI has
come from transformation studies (12). As yet, no mutant
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FIG. 4. Linked chromosomal genes for antibiotic resistance (rif,
rifampin; str, streptomycin; fus, fusidic acid; tet, tetracycline; chl,
chloramphenicol; spc, spectinomycin; ery, erythromycin; penB,
nonspecific resistance to penicillin, tetracycline, and chloramphen-
icol), resistance to serum killing by normal human serum (sac-1 and
sac-3), and PI structure (nmp-1 and nmp-2). All loci were mapped by
three-factor transformation crosses. Parentheses indicate uncertain-
ties regarding the positions of closely linked markers. Reproduced
from Annual Review of Microbiology (12) with permission of the
publisher.
strains lacking PI have been found, nor have strains been
developed which have mutations in a PI gene (13, 14, 23).
The availability of PI gene sequences for both PI subclasses
(13, 14, 23) may prove invaluable in the generation of PI
mutants, providing much-needed information about the
structure and function of PI genes and the PI molecule.
Transformation, by using both PIA- and PIB-specific MAbs
(17), and by using a selectable marker linked to PI genes (13),
has already provided several strains of N. gonorrhoeae
expressing PIA-PIB hybrids, making functional and immu-
nological studies possible.
Transformation studies have identified genetic loci, desig-
nated nmp (new membrane protein), that affect the apparent
molecular mass of PI (10). Introduction of a particular nmp
results in the expression of a unique PI (e.g., nmp-I results
in the expression of a PIB-1, nmp-3 results in a PIB-9, nmp4
results in a PIA-1, etc.) (17). The nmp loci are very closely
linked to loci that influence serum resistance (sac [serum
antibody complement]) (11) and to the penB locus (which is
probably identical to the nsr locus [nonspecific resistance]
described by Bygdeman et al. [7]), which produces low-
level, nonspecific resistance to penicillin, chloramphenicol,
and tetracycline. The nmp region is less closely linked to
genes determining resistance to streptomycin (str) and spec-
tinomycin (spc) and several other antibiotics (Fig. 4) (12). It
now appears certain that nmp are structural genes for PI
(13). Hybridization studies with PIB gene probes suggest
that the structural PI gene exists in a single copy in the
genome (23). This observation was confirmed by Carbonetti
et al. (13), who demonstrated that the PIA and PIB genes are
alleles of the same gene.
Transformation usually results in the expression of the
donor PI which has the nmp locus linked to the penB locus
(12), although occasionally the recipient PI is expressed (17).
This verifies that the penB locus can be separated from nmp.
In a study by Danielsson et al. (17), hybrid PTBs, which
acquired unique serovars, were produced in about 6% of the
transformants, in which the donor expressed PIB-1 and the
recipient expressed a PIB-7, suggesting that recombination
had occurred. A similar result was reported for PIA (15),
when a transformant generated from a PIA donor and a PIB
recipient expressed a PIA that had lost several of the
parental PIA epitopes. Moreover, when PIB donor DNA
was transformed into a PIA recipient, a single transformant
expressed a hybrid PI which had epitopes of both the PIB
and PIA molecules (17).
Such observations indicate that new PI molecules, ex-
pressing unique surface epitopes, can be generated by ge-
netic exchange between different strains of N. gonorrhoeae.
The occurrence of PIA-PIB hybrids is extremely rare in
nature (46), but the diversity of PI serovars suggests that
some form of natural recombination of PI genes does occur.
A possible mechanism for in vivo genetic exchange comes
from recent observations by Dorward and Judd (18) which
demonstrated that naturally elaborated OM blebs of N.
gonorrhoeae contain DNA. Further, it has been shown that
blebs from strains of N. gonorrhoeae which possess the gene
for penicillinase can transfer penicillin resistance to recipi-
ent, penicillin-susceptible strains with great efficiency in the
presence of high levels of exogenous deoxyribonuclease
(D. W. Dorward, C. F. Garon, and R. C. Judd, submitted for
publication). Therefore, in vivo genetic exchange between
coinfecting strains of gonococci might occur through bleb-
mediated transfer of DNA. PI may form channels between
the blebs (which have been shown to possess an abundance
of PI molecules) and the recipient cells in a manner analo-
gous to the inverted insertion of PI into eucaryotic cells (3,
49), allowing the DNA to pass from the bleb to the cell.
The close proximity of the sac-i and sac-3 loci to the nmp
loci may, in an unknown manner, contribute to the relation-
ship of serum resistance and the PIA subclass. The mecha-
nism by which the sac-I locus influences serum resistance is
unknown, but the sac-3 locus apparently effects LOS struc-
ture (71). Both sac loci influence serum resistance indepen-
dently of the nmp loci, since the three loci are separable, and
serum-resistant PIB-bearing organisms and serum-sensitive
PIA-bearing organisms have been generated by transforma-
tion (12, 69). Recent reports of a 29-kDa molecule that
correlates with serum resistance and disseminated disease
(53) may help elucidate the mechanisms) of serum resis-
tance and its relationship to PI expression.
The availability of the amino acid sequences for one PIA
(14) and two PTBs (13, 23) offers the opportunity to greatly
increase our knowledge of the gonococcal PI. Although the
PI genes have not been cloned and expressed in a stable cell
line (the PIB sequences were elucidated from clones ex-
pressing overlapping, truncated PIs, as was the PIA se-
quence, although an intact PIA was expressed in a short-
lived clone), it may now be possible to generate mutations in
PI that will greatly improve our understanding of the struc-
ture, function, and genetics of PI and hence the role PI in the
physiology, pathology, and immunobiology of N. gonor-
rhoeae.
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